Compounds > 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
Page last updated: 2024-09-04

2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and 5,10,15,20-tetra(4-pyridyl)porphyrin

2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a has been researched along with 5,10,15,20-tetra(4-pyridyl)porphyrin in 1 studies

Compound Research Comparison

Studies
(2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a)		Trials
(2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a)		Recent Studies (post-2010)
(2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a)		Studies
(5,10,15,20-tetra(4-pyridyl)porphyrin)		Trials
(5,10,15,20-tetra(4-pyridyl)porphyrin)		Recent Studies (post-2010) (5,10,15,20-tetra(4-pyridyl)porphyrin)
695391108

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fedorov, AY; Gavryushin, AE; Kudriashova, ES; Kuzmina, NS; Nyuchev, AV; Otvagin, VF1

Reviews

1 review(s) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and 5,10,15,20-tetra(4-pyridyl)porphyrin

ArticleYear
Conjugates of Porphyrinoid-Based Photosensitizers with Cytotoxic Drugs: Current Progress and Future Directions toward Selective Photodynamic Therapy.
    Journal of medicinal chemistry, 2022, 02-10, Volume: 65, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Light; Metalloporphyrins; Neoplasms; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species

2022